Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 3.170
-0.140 (-4.23%)
Sep 25, 2025, 5:35 PM CET
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €249.96 million as of September 25, 2025. Its market cap has increased by 109.24% in one year.
Market Cap
249.96M
Enterprise Value
236.97M
Revenue
7.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.17
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 249.96M, an increase of 104.89%. That is a compound annual growth rate of 7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 249.96M | 175.91% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | 210.12M | 66.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.35B |
| Laboratorios Farmaceuticos Rovi | 2.97B |
| Almirall | 2.47B |
| Pharma Mar | 1.52B |
| Faes Farma | 1.31B |
| Clínica Baviera | 693.45M |
| Laboratorio Reig Jofre | 229.52M |
| Prim, S.A. | 228.87M |